glp-1 news 2025 november Agonists Weight Loss Drugs Market Report, 2025-2030 November in review: GLP-1 breakthroughs,

Researchers are still looking into whether this means certain oral medications wont be as effective

The result is fewer side effects than the other GLP-1 agonists, along with more weight loss and better insulin control, Skelley notes

Around 30-50% of users experience side effects during the first few weeks of therapy as appetite, digestion, and metabolism begin to change

Immunohistochemical detection of alpha and beta cells was performed using rabbit anti-insulin (3014, 1:800, Cell Signaling Technology) and mouse anti glucagon (G2654, 1:1,000, Merck) as primary antibodies and goat anti-rabbit AF750 (A21039, 1:100, Invitrogen) and donkey anti-mouse AF555 (A32773, 1:200, Invitrogen) as secondary antibodies

Boost your fiber intake with unsweetened oatmeal and berries at breakfast, a salad with beans and nuts at lunch, and roasted vegetables and quinoa at dinner

Despite this, no increase in heart attacks or serious heart problems has been reported so far